Potter Clarkson Tops rankings in MIP World IP Survey 2011
01 February 2011
Potter Clarkson LLP is pleased to announce that it has been ranked in
the highest tier of UK patent firms in Managing IP's World IP Survey
Those in the top tiers received the most recommendations for the quality and depth of their practice.
Potter Clarkson LLP is pleased to announce that it has been ranked in the highest tier of UK patent firms in Managing IP's World IP Survey 2011.
MIP's team of researchers based in London, New York and Hong Kong have spoken to hundreds of practitioners and in-house counsel to gather information about the IP market. The results of this research are detailed rankings of the leading firms practising intellectual property in each country. The lists of the leading firms are presented in the form of tiers, with firms listed in alphabetical order within each tier. Those in the top tiers received the most recommendations for the quality and depth of their practice. The survey is thus a qualitative ranking of the leading firms and reveals which firms are rated by their peers for the strength of their expertise and the depth of their ability to service clients.
Managing partner Richard Bassett commented:
"We always strive to meet and exceed the expectations of our clients and deliver work of the highest quality. This top tier ranking in the latest MIP survey is gratifying because it is based on feedback from our clients and fellow professionals in rival firms. However, we certainly won't be resting on our laurels."
The editorial comments have not yet been published by MIP, but in its 2010 survey it stated:
"Of the provincial attorney firms, Potter Clarkson is the clear leader for patent work. Based in a single Nottingham office, the firm has a "no generalists" approach and operates a highly specialised practice with clearly delineated teams. For the biotechnology and pharmaceuticals team, which consists of 20 attorneys and is one of the UK's biggest, 2009 was a particularly busy year. Under the leadership of managing partner Richard Bassett, it represented AstraZeneca in EPO proceedings to gain protection for its product Nexium - one of the world's biggest-selling drugs. The firm has a balanced client list in which companies from the UK, US, Japan and Scandinavia all feature. One client praised the firm for its personal approach: "They make you feel like you're on their radar and that you are important to them. I feel safe and secure acting on their advice."